Alpine Immune Sciences Probability of Future Stock Price Finishing Over 8.61
| ALPNDelisted Stock | USD 12.37 0.23 1.83% |
Alpine |
Alpine Immune Target Price Odds to finish over 8.61
The tendency of Alpine Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to stay above $ 8.61 in 90 days |
| 12.37 | 90 days | 8.61 | about 75.14 |
Based on a normal probability distribution, the odds of Alpine Immune to stay above $ 8.61 in 90 days from now is about 75.14 (This Alpine Immune Sciences probability density function shows the probability of Alpine Stock to fall within a particular range of prices over 90 days) . Probability of Alpine Immune Sciences price to stay between $ 8.61 and its current price of $12.37 at the end of the 90-day period is about 69.65 .
Given the investment horizon of 90 days Alpine Immune Sciences has a beta of -0.65. This suggests as returns on the benchmark increase, returns on holding Alpine Immune are expected to decrease at a much lower rate. During a bear market, however, Alpine Immune Sciences is likely to outperform the market. Additionally Alpine Immune Sciences has an alpha of 0.8862, implying that it can generate a 0.89 percent excess return over Dow Jones Industrial after adjusting for the inherited market risk (beta). Alpine Immune Price Density |
| Price |
Predictive Modules for Alpine Immune
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Alpine Immune Sciences. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Alpine Immune Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Alpine Immune is not an exception. The market had few large corrections towards the Alpine Immune's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Alpine Immune Sciences, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Alpine Immune within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | 0.89 | |
β | Beta against Dow Jones | -0.65 | |
σ | Overall volatility | 1.65 | |
Ir | Information ratio | 0.20 |
Alpine Immune Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Alpine Immune for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Alpine Immune Sciences can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Alpine Immune is not yet fully synchronised with the market data | |
| Alpine Immune has a very high chance of going through financial distress in the upcoming years | |
| The company reported the previous year's revenue of 58.88 M. Net Loss for the year was (32.18 M) with loss before overhead, payroll, taxes, and interest of (40.18 M). | |
| Alpine Immune Sciences currently holds about 167.86 M in cash with (79.01 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 5.52. | |
| Over 99.0% of the company shares are held by institutions such as insurance companies |
Alpine Immune Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Alpine Stock often depends not only on the future outlook of the current and potential Alpine Immune's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Alpine Immune's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 50 M | |
| Cash And Short Term Investments | 327.4 M |
Alpine Immune Technical Analysis
Alpine Immune's future price can be derived by breaking down and analyzing its technical indicators over time. Alpine Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Alpine Immune Sciences. In general, you should focus on analyzing Alpine Stock price patterns and their correlations with different microeconomic environments and drivers.
Alpine Immune Predictive Forecast Models
Alpine Immune's time-series forecasting models is one of many Alpine Immune's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Alpine Immune's historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about Alpine Immune Sciences
Checking the ongoing alerts about Alpine Immune for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Alpine Immune Sciences help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| Alpine Immune is not yet fully synchronised with the market data | |
| Alpine Immune has a very high chance of going through financial distress in the upcoming years | |
| The company reported the previous year's revenue of 58.88 M. Net Loss for the year was (32.18 M) with loss before overhead, payroll, taxes, and interest of (40.18 M). | |
| Alpine Immune Sciences currently holds about 167.86 M in cash with (79.01 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 5.52. | |
| Over 99.0% of the company shares are held by institutions such as insurance companies |
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey. You can also try the Portfolio Optimization module to compute new portfolio that will generate highest expected return given your specified tolerance for risk.
Other Consideration for investing in Alpine Stock
If you are still planning to invest in Alpine Immune Sciences check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Alpine Immune's history and understand the potential risks before investing.
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum |